Active surveillance Definitive treatment Neoadjuvant treatment Sarcoma Chemotherapy TNM staging system Maintenance chemotherapy Performance status Complementary therapy Liquid tumor Lymphoma Grade 3, 4, or 5 Cure Multiple myeloma Pathological stage Surgical margin Complete remission Partial remission Cellular therapy Clinical stage Leukemia CTCAE Adenocarcinoma Minimal residual disease Palliation Monoclonal antibody PET scan Adjuvant treatment ECOG performance status Cancer Refractory Tyrosine kinase inhibitors (TKIs) Tumor Carcinoma Benign Checkpoint inhibitor Recurrence or relapse Antibody drug conjugate Active surveillance Definitive treatment Neoadjuvant treatment Sarcoma Chemotherapy TNM staging system Maintenance chemotherapy Performance status Complementary therapy Liquid tumor Lymphoma Grade 3, 4, or 5 Cure Multiple myeloma Pathological stage Surgical margin Complete remission Partial remission Cellular therapy Clinical stage Leukemia CTCAE Adenocarcinoma Minimal residual disease Palliation Monoclonal antibody PET scan Adjuvant treatment ECOG performance status Cancer Refractory Tyrosine kinase inhibitors (TKIs) Tumor Carcinoma Benign Checkpoint inhibitor Recurrence or relapse Antibody drug conjugate
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Active surveillance
Definitive treatment
Neoadjuvant treatment
Sarcoma
Chemotherapy
TNM staging system
Maintenance chemotherapy
Performance status
Complementary therapy
Liquid tumor
Lymphoma
Grade 3, 4, or 5
Cure
Multiple myeloma
Pathological stage
Surgical margin
Complete remission
Partial remission
Cellular therapy
Clinical stage
Leukemia
CTCAE
Adenocarcinoma
Minimal residual disease
Palliation
Monoclonal antibody
PET scan
Adjuvant treatment
ECOG performance status
Cancer
Refractory
Tyrosine kinase inhibitors (TKIs)
Tumor
Carcinoma
Benign
Checkpoint inhibitor
Recurrence or relapse
Antibody drug conjugate